Literature DB >> 8630593

Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.

M Robinson1, J A Regnis, D L Bailey, M King, G J Bautovich, P T Bye.   

Abstract

In patients with cystic fibrosis (CF), dehydration of airway secretions leads to a decrease in mucociliary clearance (MCC). We examined the acute effect of MCC of a single administration by aerosolization of hypertonic saline (7%) (HS), amiloride (0.3% in 0.12% NaCl) (AML) and a combination of AML and HS (AML + HS) in 12 patients with CF using a radioaerosol technique. Isotonic saline [0.9%] (IS) was used as a control solution. As both the AML and HS solutions induced cough in some patients, the last nine patients studied also underwent a cough clearance day. This was to eliminate the possible confounding effect of cough on MCC measurement. Patients ranged from 18 to 28 yr (mean +/- SD, 22 +/- 3) with an FEV1 of 27 to 112% predicted (61 +/- 30%). Following deposition of the radioaerosol, baseline clearance was assessed for 30 min. This was followed by a 30-min intervention period. Assessment of post-intervention clearance for a further 30 min was then performed. Comparison of the amount of radioaerosol cleared from the right lung was made at 60 min (%C60) and 90 min (%C90) using repeated measures ANOVA. The percent cleared at 60 and 90 min was significantly increased with HS (%C60 = 26.5%, %C90 = 29.4%) and the combination of AML + HS (%C60 = 23.1%, %C90 = 27.4%) compared with both IS (%C60 = 14.7%, %C90 = 17.5%) and COUGH (%C60 = 18.0%, %C90 = 19.5%), p < 0.01. Inhalation of hypertonic saline is a potentially useful treatment in patients with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630593     DOI: 10.1164/ajrccm.153.5.8630593

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  47 in total

Review 1.  Pathogenesis of cystic fibrosis airways disease.

Authors:  R C Boucher
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

2.  The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing.

Authors:  J Zabner; M P Seiler; J L Launspach; P H Karp; W R Kearney; D C Look; J J Smith; M J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  Hypertonic saline inhalation in cystic fibrosis--salt in the wound, or sweet success?

Authors:  Beth Enderby; Iolo Doull
Journal:  Arch Dis Child       Date:  2007-03       Impact factor: 3.791

Review 4.  Timing of hypertonic saline inhalation for cystic fibrosis.

Authors:  Mark Elkins; Ruth Dentice
Journal:  Cochrane Database Syst Rev       Date:  2016-12-22

5.  Effects of buffered 2.3%, buffered 0.9%, and non-buffered 0.9% irrigation solutions on nasal mucosa after septoplasty.

Authors:  Nilda Süslü; Münir Demir Bajin; Ahmet Emre Süslü; Oğuz Oğretmenoğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-18       Impact factor: 2.503

Review 6.  Mechanisms and applications of hypertonic saline.

Authors:  Mark R Elkins; Peter T P Bye
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

7.  Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea.

Authors:  P J Wills; R L Hall; W Chan; P J Cole
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

8.  Chronic Bronchitis: Where Are We Now?

Authors:  Yaniv Dotan; Jennifer Y So; Victor Kim
Journal:  Chronic Obstr Pulm Dis       Date:  2019-04-09

9.  Duration of action of hypertonic saline on mucociliary clearance in the normal lung.

Authors:  W D Bennett; J Wu; F Fuller; J R Balcazar; K L Zeman; H Duckworth; K H Donn; T G O'Riordan; R C Boucher; S H Donaldson
Journal:  J Appl Physiol (1985)       Date:  2015-04-24

10.  Vagal control of mucociliary clearance in murine lungs: a study in a chronic preparation.

Authors:  Abhiram R Bhashyam; Peter J Mogayzel; Jeffrey C Cleary; Bradley J Undem; Marian Kollarik; James Fox; Beth L Laube
Journal:  Auton Neurosci       Date:  2010-01-03       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.